Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT00106574

Public ClinicalTrials.gov record NCT00106574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind Study of the Effect of Tocilizumab on Reduction in Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to DMARD Therapy

Study identification

NCT ID
NCT00106574
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,220 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • tocilizumab [RoActemra/Actemra] Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2005
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007
Last update posted
Nov 1, 2016

2005 – 2007

United States locations

U.S. sites
76
U.S. states
33
U.S. cities
74
Facility City State ZIP Site status
Not listed Mesa Arizona 85208
Not listed Paradise Valley Arizona 85253
Not listed Peoria Arizona 85381
Not listed Scottsdale Arizona 85258
Not listed Tucson Arizona 85723
Not listed Little Rock Arkansas 72205
Not listed Los Angeles California 90048
Not listed Palm Desert California 92260
Not listed Palo Alto California 94304
Not listed San Jose California 95126
Not listed Upland California 91786
Not listed Newark Delaware 19713
Not listed Washington D.C. District of Columbia 20006
Not listed Delray Beach Florida 33484
Not listed Jupiter Florida 33458
Not listed Palm Habor Florida 34684
Not listed Palm Harbor Florida 34684
Not listed Tampa Florida 33609
Not listed Chicago Illinois 60611
Not listed Chicago Illinois 60637
Not listed Springfield Illinois 62704
Not listed Vernon Hills Illinois 60061
Not listed Indianapolis Indiana 46202
Not listed Bowling Green Kentucky 42102
Not listed Baton Rouge Louisiana 70808
Not listed Shreverport Louisiana 71103
Not listed Frederick Maryland 21702
Not listed Boston Massachusetts 02111
Not listed Lansing Michigan 48910
Not listed Duluth Minnesota 55805
Not listed Eagan Minnesota 55121
Not listed Saint Louis Park Minnesota 55426
Not listed Springfield Missouri 65807
Not listed St Louis Missouri 63117
Not listed Lincoln Nebraska 68516
Not listed Reno Nevada 89502
Not listed Clifton New Jersey 07012
Not listed Haddon Heights New Jersey 08035
Not listed New Brunswick New Jersey 08903
Not listed Albuquerque New Mexico 87131
Not listed New York New York 10021
Not listed Plainview New York 11803
Not listed Roslyn New York 11576
Not listed Smithtown New York 11787
Not listed Syracuse New York 13210
Not listed Durham North Carolina 27704
Not listed Raleigh North Carolina 27609
Not listed Winston-Salem North Carolina 27157
Not listed Beachwood Ohio 44122
Not listed Cincinnati Ohio 45219
Not listed Dayton Ohio 45408
Not listed Gallipolis Ohio 45631
Not listed Oklahoma City Oklahoma 73103
Not listed Oklahoma City Oklahoma 73112
Not listed Tulsa Oklahoma 74104
Not listed Medford Oregon 97504
Not listed Allentown Pennsylvania 18103
Not listed Bethlehem Pennsylvania 18015
Not listed Philadelphia Pennsylvania 19152
Not listed Pittsburgh Pennsylvania 15261
Not listed Rockledge Pennsylvania 19046
Not listed Willow Grove Pennsylvania 19090
Not listed Johnston Rhode Island 02919
Not listed Charleston South Carolina 29406
Not listed Hixson Tennessee 37343
Not listed Nashville Tennessee 37203
Not listed Austin Texas 78705
Not listed Houston Texas 77074
Not listed Mesquite Texas 75150
Not listed Burlington Vermont 05401
Not listed Arlington Virginia 22204
Not listed Spokane Washington 99204
Not listed Tacoma Washington 98405
Not listed Vancouver Washington 98664
Not listed La Crosse Wisconsin 54601
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106574 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →